Large-scale Proteomics Analysis of the Human Kinome

被引:234
作者
Oppermann, Felix S. [1 ]
Gnad, Florian
Olsen, Jesper V. [2 ]
Hornberger, Renate [1 ]
Greff, Zoltan [3 ]
Keri, Gyoergy [3 ,4 ]
Mann, Matthias [2 ]
Daub, Henrik [1 ]
机构
[1] Max Planck Inst Biochem, Dept Mol Biol, Cell Signaling Grp, D-82152 Martinsried, Germany
[2] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany
[3] Vichem Chem Ltd, H-1022 Budapest, Hungary
[4] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, H-1088 Budapest, Hungary
关键词
QUANTITATIVE PHOSPHOPROTEOMICS; PHOSPHORYLATION ANALYSIS; KINASE INHIBITORS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; SELECTIVE ENRICHMENT; CHEMICAL PROTEOMICS; TYROSINE KINASES; CELLULAR TARGETS; CANCER-THERAPY;
D O I
10.1074/mcp.M800588-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Members of the human protein kinase superfamily are the major regulatory enzymes involved in the activity control of eukaryotic signal transduction pathways. As protein kinases reside at the nodes of phosphorylation-based signal transmission, comprehensive analysis of their cellular expression and site-specific phosphorylation can provide important insights into the architecture and functionality of signaling networks. However, in global proteome studies, low cellular abundance of protein kinases often results in rather minor peptide species that are occluded by a vast excess of peptides from other cellular proteins. These analytical limitations create a rationale for kinome-wide enrichment of protein kinases prior to mass spectrometry analysis. Here, we employed stable isotope labeling by amino acids in cell culture (SILAC) to compare the binding characteristics of three kinase-selective affinity resins by quantitative mass spectrometry. The evaluated pre-fractionation tools possessed pyrido[2,3-d] pyrimidine-based kinase inhibitors as immobilized capture ligands and retained considerable subsets of the human kinome. Based on these results, an affinity resin displaying the broadly selective kinase ligand VI16832 was employed to quantify the relative expression of more than 170 protein kinases across three different, SILAC-encoded cancer cell lines. These experiments demonstrated the feasibility of comparative kinome profiling in a compact experimental format. Interestingly, we found high levels of cytoplasmic and low levels of receptor tyrosine kinases in MV4-11 leukemia cells compared with the adherent cancer lines HCT116 and MDA-MB-435S. The VI16832 resin was further exploited to pre-fractionate kinases for targeted phosphoproteomics analysis, which revealed about 1200 distinct phosphorylation sites on more than 200 protein kinases. This hitherto largest survey of site-specific phosphorylation across the kinome significantly expands the basis for functional follow-up studies on protein kinase regulation. In conclusion, the straightforward experimental procedures described here enable different implementations of kinase-selective proteomics with considerable potential for future signal transduction and kinase drug target analysis. Molecular & Cellular Proteomics 8: 1751-1764, 2009.
引用
收藏
页码:1751 / 1764
页数:14
相关论文
共 47 条
[1]   The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins [J].
Adachi, Jun ;
Kumar, Chanchal ;
Zhang, Yanling ;
Olsen, Jesper V. ;
Mann, Matthias .
GENOME BIOLOGY, 2006, 7 (09)
[2]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[3]   Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases [J].
Barvian, M ;
Boschelli, DH ;
Cossrow, J ;
Dobrusin, E ;
Fattaey, A ;
Fritsch, A ;
Fry, D ;
Harvey, P ;
Keller, P ;
Garrett, M ;
La, F ;
Leopold, W ;
McNamara, D ;
Quin, M ;
Trumpp-Kallmeyer, S ;
Toogood, P ;
Wu, ZP ;
Zhang, EL .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (24) :4606-4616
[4]   Large-scale characterization of HeLa cell nuclear phosphoproteins [J].
Beausoleil, SA ;
Jedrychowski, M ;
Schwartz, D ;
Elias, JE ;
Villén, J ;
Li, JX ;
Cohn, MA ;
Cantley, LC ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12130-12135
[5]   Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors [J].
Blencke, S ;
Zech, B ;
Engkvist, O ;
Greff, Z ;
Örfi, L ;
Horváth, Z ;
Kéri, G ;
Ullrich, A ;
Daub, H .
CHEMISTRY & BIOLOGY, 2004, 11 (05) :691-701
[6]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[7]  
Brehmer D, 2005, CANCER RES, V65, P379
[8]   Analysis of protein phosphorylation on a proteome-scale [J].
Collins, Mark O. ;
Yu, Lu ;
Choudhary, Jyoti S. .
PROTEOMICS, 2007, 7 (16) :2751-2768
[9]   Characterisation of kinase-selective inhibitors by chemical proteomics [J].
Daub, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2) :183-190
[10]   Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle [J].
Daub, Henrik ;
Olsen, Jesper V. ;
Bairlein, Michaela ;
Gnad, Florian ;
Oppermann, Felix S. ;
Koerner, Roman ;
Greff, Zoltan ;
Keri, Gyoergy ;
Stemmann, Olaf ;
Mann, Matthias .
MOLECULAR CELL, 2008, 31 (03) :438-448